CA2501089C - Composes antitumoraux - Google Patents
Composes antitumoraux Download PDFInfo
- Publication number
- CA2501089C CA2501089C CA2501089A CA2501089A CA2501089C CA 2501089 C CA2501089 C CA 2501089C CA 2501089 A CA2501089 A CA 2501089A CA 2501089 A CA2501089 A CA 2501089A CA 2501089 C CA2501089 C CA 2501089C
- Authority
- CA
- Canada
- Prior art keywords
- cancer
- compound
- kahalalide
- val
- allo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Abstract
L'invention concerne des composés antitumoraux kahalalide, notamment des analogues de kahalalide F, utiles en tant qu'agents antitumoraux, antiviraux, antifongiques et dans le traitement du psoriasis.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBPCT/GB02/004735 | 2002-10-18 | ||
PCT/GB2002/004735 WO2003033012A1 (fr) | 2001-10-19 | 2002-10-18 | Composes a base de kahalalide utilisables en therapie anticancereuse |
GB0304367.6 | 2003-02-26 | ||
GBGB0304367.6A GB0304367D0 (en) | 2003-02-26 | 2003-02-26 | Methods for treating psoriasis |
GB0314725A GB0314725D0 (en) | 2003-06-24 | 2003-06-24 | New antitumoral compounds |
GB0314725.3 | 2003-06-24 | ||
PCT/US2003/033207 WO2004035613A2 (fr) | 2002-10-18 | 2003-10-20 | Composes antitumoraux |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2501089A1 CA2501089A1 (fr) | 2004-04-29 |
CA2501089C true CA2501089C (fr) | 2012-07-17 |
Family
ID=32110555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2501089A Expired - Fee Related CA2501089C (fr) | 2002-10-18 | 2003-10-20 | Composes antitumoraux |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1572726B1 (fr) |
JP (1) | JP4430009B2 (fr) |
CN (2) | CN101077885A (fr) |
BR (1) | BR0315489A (fr) |
CA (1) | CA2501089C (fr) |
ES (1) | ES2357644T3 (fr) |
MX (1) | MXPA05004133A (fr) |
NZ (1) | NZ539093A (fr) |
WO (1) | WO2004035613A2 (fr) |
ZA (1) | ZA200502926B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6274551B1 (en) * | 1994-02-03 | 2001-08-14 | Pharmamar, S.A. | Cytotoxic and antiviral compound |
GB0304367D0 (en) * | 2003-02-26 | 2003-04-02 | Pharma Mar Sau | Methods for treating psoriasis |
US7507708B2 (en) | 2003-02-26 | 2009-03-24 | Pharma Mar, S.A.U. | Antitumoral compounds |
GB0321066D0 (en) | 2003-09-09 | 2003-10-08 | Pharma Mar Sau | New antitumoral compounds |
EP2207561A2 (fr) * | 2007-10-19 | 2010-07-21 | Pharma Mar, S.A. | Traitements antitumoraux améliorés |
DE102008005097B4 (de) * | 2008-01-18 | 2011-04-07 | Leibnitz-Institut für Meereswissenschaften | Antitumoraler Cyclodepsipeptide, deren Herstellung und Verwendung |
WO2009109649A1 (fr) * | 2008-03-07 | 2009-09-11 | Pharma Mar, S.A. | Traitements anti-tumoraux améliorés |
WO2009135939A2 (fr) * | 2008-05-09 | 2009-11-12 | Pharma Mar, S.A. | Depsipeptide pour une utilisation dans la thérapie du cancer |
RS58609B1 (sr) | 2010-11-12 | 2019-05-31 | Pharma Mar Sa | Kombinovana terapija sa inhibitorom mitoze |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6274551B1 (en) * | 1994-02-03 | 2001-08-14 | Pharmamar, S.A. | Cytotoxic and antiviral compound |
GB9302046D0 (en) * | 1993-02-03 | 1993-03-24 | Pharma Mar Sa | Antiumoral compound-v |
WO2002036145A2 (fr) * | 2000-10-31 | 2002-05-10 | Pharma Mar, S.A. | Kahalalide f |
CA2462639A1 (fr) * | 2001-10-19 | 2003-04-24 | Pharma Mar, S.A. | Composes a base de kahalalide utilisables en therapie anticancereuse |
-
2003
- 2003-10-20 EP EP03779140A patent/EP1572726B1/fr not_active Expired - Lifetime
- 2003-10-20 CA CA2501089A patent/CA2501089C/fr not_active Expired - Fee Related
- 2003-10-20 JP JP2005501483A patent/JP4430009B2/ja not_active Expired - Fee Related
- 2003-10-20 ES ES03779140T patent/ES2357644T3/es not_active Expired - Lifetime
- 2003-10-20 CN CNA2007101122538A patent/CN101077885A/zh active Pending
- 2003-10-20 WO PCT/US2003/033207 patent/WO2004035613A2/fr active Application Filing
- 2003-10-20 MX MXPA05004133A patent/MXPA05004133A/es active IP Right Grant
- 2003-10-20 BR BR0315489-0A patent/BR0315489A/pt not_active IP Right Cessation
- 2003-10-20 CN CN200380101647A patent/CN100591691C/zh not_active Expired - Fee Related
- 2003-10-20 NZ NZ539093A patent/NZ539093A/en not_active IP Right Cessation
-
2005
- 2005-04-11 ZA ZA200502926A patent/ZA200502926B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BR0315489A (pt) | 2005-08-23 |
JP2006517195A (ja) | 2006-07-20 |
CN100591691C (zh) | 2010-02-24 |
ZA200502926B (en) | 2006-02-22 |
NZ539093A (en) | 2007-10-26 |
JP4430009B2 (ja) | 2010-03-10 |
WO2004035613A2 (fr) | 2004-04-29 |
CA2501089A1 (fr) | 2004-04-29 |
EP1572726A2 (fr) | 2005-09-14 |
WO2004035613A3 (fr) | 2004-07-29 |
ES2357644T3 (es) | 2011-04-28 |
EP1572726B1 (fr) | 2010-12-08 |
CN1705677A (zh) | 2005-12-07 |
CN101077885A (zh) | 2007-11-28 |
MXPA05004133A (es) | 2005-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7683028B2 (en) | Kahalalide compositions | |
JP5372096B2 (ja) | 新規な抗腫瘍化合物 | |
CA2501089C (fr) | Composes antitumoraux | |
RU2356908C2 (ru) | Новые противоопухолевые соединения | |
AU2003285911B2 (en) | 4-methylhexanoic kahalaide F compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20171020 |